{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:07:23Z","timestamp":1788469643132,"version":"build-2803163510"},"reference-count":111,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T00:00:00Z","timestamp":1609372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>\n                    Infections with the protozoan parasite\n                    <jats:italic>Toxoplasma gondii<\/jats:italic>\n                    are frequent, but one of its main consequences, ocular toxoplasmosis (OT), remains poorly understood. While its clinical description has recently attracted more attention and publications, the underlying pathophysiological mechanisms are only sparsely elucidated, which is partly due to the inherent difficulties to establish relevant animal models. Furthermore, the particularities of the ocular environment explain why the abundant knowledge on systemic toxoplasmosis cannot be just transferred to the ocular situation. However, studies undertaken in mouse models have revealed a central role of interferon gamma (IFN\u03b3) and, more surprisingly, interleukin 17 (IL17), in ocular pathology and parasite control. These studies also show the importance of the genetic background of the infective\n                    <jats:italic>Toxoplasma<\/jats:italic>\n                    strain. Indeed, infections due to exotic strains show a completely different pathophysiology, which translates in a different clinical outcome. These elements should lead to more individualized therapy. Furthermore, the recent advance in understanding the immune response during OT paved the way to new research leads, involving immune pathways poorly studied in this particular setting, such as type I and type III interferons. In any case, deeper knowledge of the mechanisms of this pathology is needed to establish new, more targeted treatment schemes.\n                  <\/jats:p>","DOI":"10.1371\/journal.pntd.0008905","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T13:33:39Z","timestamp":1609421619000},"page":"e0008905","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Pathophysiology of ocular toxoplasmosis: Facts and open questions"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0975-1949","authenticated-orcid":true,"given":"Valentin","family":"Greigert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9191-0370","authenticated-orcid":true,"given":"Faiza","family":"Bittich-Fahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-1803","authenticated-orcid":true,"given":"Alexander W.","family":"Pfaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,12,31]]},"reference":[{"key":"pntd.0008905.ref001","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"JG Montoya","year":"2004","journal-title":"Lancet Lond Engl"},{"key":"pntd.0008905.ref002","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ajo.2003.09.040","article-title":"Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease","volume":"136","author":"GN Holland","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"pntd.0008905.ref003","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpara.2013.09.007","article-title":"New clinical and experimental insights into Old World and neotropical ocular toxoplasmosis","volume":"44","author":"AW Pfaff","year":"2014","journal-title":"Int J Parasitol"},{"key":"pntd.0008905.ref004","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1590\/S0074-02762009000200030","article-title":"Ocular toxoplasmosis: an update and review of the literature","volume":"104","author":"AG Commodaro","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"pntd.0008905.ref005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000363141","article-title":"Ocular Toxoplasmosis: Recent Aspects of Pathophysiology and Clinical Implications","volume":"52","author":"U Pleyer","year":"2014","journal-title":"Ophthalmic Res"},{"key":"pntd.0008905.ref006","article-title":"When biology supports clinical diagnosis: review of techniques to diagnose ocular toxoplasmosis","author":"V Greigert","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"pntd.0008905.ref007","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/ICU.0000000000000205","article-title":"Ocular toxoplasmosis: background and evidence for an antibiotic prophylaxis","volume":"26","author":"M Reich","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"pntd.0008905.ref008","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1055\/s-0041-111821","article-title":"Ocular Toxoplasmosis: an Update","volume":"233","author":"JG Garweg","year":"2016","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"pntd.0008905.ref009","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.exppara.2004.03.014","article-title":"Massive excystation of Toxoplasma gondii sporozoites","volume":"107","author":"A Freyre","year":"2004","journal-title":"Exp Parasitol"},{"key":"pntd.0008905.ref010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/21505594.2018.1518102","article-title":"The role of host autophagy machinery in controlling Toxoplasma infection","volume":"10","author":"S Besteiro","year":"2019","journal-title":"Virulence"},{"key":"pntd.0008905.ref011","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/mi.2014.25","article-title":"Border maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii","volume":"7","author":"SB Cohen","year":"2014","journal-title":"Mucosal Immunol"},{"key":"pntd.0008905.ref012","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1462-5822.2005.00486.x","article-title":"Transepithelial migration of Toxoplasma gondii involves an interaction of intercellular adhesion molecule 1 (ICAM-1) with the parasite adhesin MIC2","volume":"7","author":"A Barragan","year":"2005","journal-title":"Cell Microbiol"},{"key":"pntd.0008905.ref013","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/IAI.05899-11","article-title":"Tissue barriers of the human placenta to infection with Toxoplasma gondii","volume":"80","author":"JR Robbins","year":"2012","journal-title":"Infect Immun"},{"key":"pntd.0008905.ref014","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1189\/jlb.1211600","article-title":"A synthetic peptide derived from the parasite Toxoplasma gondii triggers human dendritic cells\u2019 migration","volume":"92","author":"F Persat","year":"2012","journal-title":"J Leukoc Biol"},{"key":"pntd.0008905.ref015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.parint.2008.06.004","article-title":"Dissemination of extracellular and intracellular Toxoplasma gondii tachyzoites in the blood flow","volume":"57","author":"A Unno","year":"2008","journal-title":"Parasitol Int"},{"key":"pntd.0008905.ref016","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2005-02-0666","article-title":"CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain","volume":"107","author":"N Courret","year":"2006","journal-title":"Blood"},{"key":"pntd.0008905.ref017","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.micinf.2004.07.008","article-title":"Reduction in adhesiveness to extracellular matrix components, modulation of adhesion molecules and in vivo migration of murine macrophages infected with Toxoplasma gondii","volume":"6","author":"LM Da Gama","year":"2004","journal-title":"Microbes Infect"},{"key":"pntd.0008905.ref018","first-page":"1735","article-title":"Rapid cytoskeleton remodelling in dendritic cells following invasion by Toxoplasma gondii coincides with the onset of a hypermigratory phenotype","volume":"15","author":"JM Weidner","year":"2013","journal-title":"Cell Microbiol"},{"key":"pntd.0008905.ref019","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/cmi.12239","article-title":"Real-time imaging of Toxoplasma-infected human monocytes under fluidic shear stress reveals rapid translocation of intracellular parasites across endothelial barriers","volume":"16","author":"N Ueno","year":"2014","journal-title":"Cell Microbiol"},{"key":"pntd.0008905.ref020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/CMR.11.2.267","article-title":"Structures of Toxoplasma gondii Tachyzoites, Bradyzoites, and Sporozoites and Biology and Development of Tissue Cysts","volume":"11","author":"JP Dubey","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"pntd.0008905.ref021","volume-title":"Clinical Anatomy of the Eye","author":"RS Snell","year":"2013"},{"key":"pntd.0008905.ref022","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nri.2017.100","article-title":"Organ-specific protection mediated by cooperation between vascular and epithelial barriers","volume":"17","author":"I Spadoni","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"pntd.0008905.ref023","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.neuron.2017.02.043","article-title":"Gradual Suppression of Transcytosis Governs Functional Blood-Retinal Barrier Formation","volume":"93","author":"BW Chow","year":"2017","journal-title":"Neuron"},{"key":"pntd.0008905.ref024","first-page":"299","article-title":"The role of retinal pigment epithelium in visual functions","volume":"106","author":"O Strauss","year":"2009","journal-title":"Ophthalmol Z Dtsch Ophthalmol Ges"},{"key":"pntd.0008905.ref025","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/icb.2012.21","article-title":"Toxoplasma gondii tachyzoites cross retinal endothelium assisted by intercellular adhesion molecule-1 in vitro","volume":"90","author":"JM Furtado","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"pntd.0008905.ref026","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1167\/iovs.12-10384","article-title":"Migration of Toxoplasma gondii-infected dendritic cells across human retinal vascular endothelium","volume":"53","author":"JM Furtado","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"pntd.0008905.ref027","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00436-018-5950-3","article-title":"Investigation of tissue cysts in the retina in a mouse model of ocular toxoplasmosis: distribution and interaction with glial cells","volume":"117","author":"HB Song","year":"2018","journal-title":"Parasitol Res"},{"key":"pntd.0008905.ref028","volume-title":"Anatomie de l\u2019\u0152il","author":"M Santallier"},{"key":"pntd.0008905.ref029","article-title":"Retinal Macroglial Responses in Health and Disease","author":"R de Hoz","year":"2016","journal-title":"Biomed Res Int"},{"key":"pntd.0008905.ref030","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"F Ginhoux","year":"2010","journal-title":"Science"},{"key":"pntd.0008905.ref031","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.exer.2015.04.020","article-title":"The microglia in healthy and diseased retina","volume":"136","author":"L Li","year":"2015","journal-title":"Exp Eye Res"},{"key":"pntd.0008905.ref032","article-title":"Immune cells in the retina and choroid: Two different tissue environments that require different defenses and surveillance","author":"PG McMenamin","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"pntd.0008905.ref033","doi-asserted-by":"crossref","first-page":"e54358","DOI":"10.1371\/journal.pone.0054358","article-title":"Toxoplasma gondii migration within and infection of human retina","volume":"8","author":"JM Furtado","year":"2013","journal-title":"PLoS ONE"},{"key":"pntd.0008905.ref034","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3389\/fmicb.2019.00899","article-title":"Strategies Developed by Toxoplasma gondii to Survive in the Host","volume":"10","author":"W Zhu","year":"2019","journal-title":"Front Microbiol"},{"key":"pntd.0008905.ref035","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.micinf.2011.08.013","article-title":"Analysis of the glycoproteome of Toxoplasma gondii using lectin affinity chromatography and tandem mass spectrometry","volume":"13","author":"Q Luo","year":"2011","journal-title":"Microbes Infect"},{"key":"pntd.0008905.ref036","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/EC.00343-12","article-title":"Bradyzoite pseudokinase 1 is crucial for efficient oral infectivity of the Toxoplasma gondii tissue cyst","volume":"12","author":"KR Buchholz","year":"2013","journal-title":"Eukaryot Cell"},{"key":"pntd.0008905.ref037","doi-asserted-by":"crossref","first-page":"e1003331","DOI":"10.1371\/journal.ppat.1003331","article-title":"A nucleotide sugar transporter involved in glycosylation of the Toxoplasma tissue cyst wall is required for efficient persistence of bradyzoites","volume":"9","author":"CE Caffaro","year":"2013","journal-title":"PLoS Pathog"},{"key":"pntd.0008905.ref038","doi-asserted-by":"crossref","first-page":"e1003823","DOI":"10.1371\/journal.ppat.1003823","article-title":"The Toxoplasma gondii cyst wall protein CST1 is critical for cyst wall integrity and promotes bradyzoite persistence","volume":"9","author":"T Tomita","year":"2013","journal-title":"PLoS Pathog"},{"key":"pntd.0008905.ref039","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1017\/S0031182017002050","article-title":"Toxoplasma gondii reorganizes the host cell architecture during spontaneous cyst formation in vitro","volume":"145","author":"TC Paredes-Santos","year":"2018","journal-title":"Parasitology"},{"key":"pntd.0008905.ref040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9394(14)73415-4","article-title":"Factors related to the initiation and recurrence of uveitis. XL Edward Jackson memorial lecture","volume":"96","author":"GR O\u2019Connor","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"pntd.0008905.ref041","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0161-6420(01)00845-4","article-title":"Reactivations of ocular toxoplasmosis after cataract extraction","volume":"109","author":"LH Bosch-Driessen","year":"2002","journal-title":"Ophthalmology"},{"key":"pntd.0008905.ref042","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1471-0528.2004.00302.x","article-title":"Reactivation of ocular toxoplasmosis during pregnancy","volume":"112","author":"JG Garweg","year":"2005","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"pntd.0008905.ref043","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0002-9394(88)90697-6","article-title":"Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome","volume":"106","author":"GN Holland","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"pntd.0008905.ref044","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00006982-199616050-00003","article-title":"Recurrent ocular toxoplasmosis in patients treated with systemic corticosteroids","volume":"16","author":"PJ Morhun","year":"1996","journal-title":"Retina Phila Pa"},{"key":"pntd.0008905.ref045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9394(02)01324-7","article-title":"Ocular toxoplasmosis after the fifth decade","volume":"133","author":"P Labalette","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"pntd.0008905.ref046","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ajo.2018.11.013","article-title":"Clinical and Biological Factors Associated With Recurrences of Severe Toxoplasmic Retinochoroiditis Confirmed by Aqueous Humor Analysis","volume":"199","author":"A Matet","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"pntd.0008905.ref047","first-page":"1823","article-title":"Analysis of immune deviation elicited by antigens injected into the subretinal space","volume":"39","author":"H Wenkel","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"pntd.0008905.ref048","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"DL Nickla","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"pntd.0008905.ref049","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jlb.67.4.479","article-title":"Does innate immune privilege exist?","volume":"67","author":"JW Streilein","year":"2000","journal-title":"J Leukoc Biol"},{"key":"pntd.0008905.ref050","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-gamma: the major mediator of resistance against Toxoplasma gondii","volume":"240","author":"Y Suzuki","year":"1988","journal-title":"Science"},{"key":"pntd.0008905.ref051","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fcimb.2019.00136","article-title":"Toxoplasma gondii: CD8 T Cells Cry for CD4 Help","volume":"9","author":"IA Khan","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"pntd.0008905.ref052","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.pt.2019.08.005","article-title":"CD8+ T Cell Responses to Toxoplasma gondii: Lessons from a Successful Parasite","volume":"35","author":"A Tsitsiklis","year":"2019","journal-title":"Trends Parasitol"},{"key":"pntd.0008905.ref053","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nri3598","article-title":"Innate immunity to Toxoplasma gondii infection","volume":"14","author":"F Yarovinsky","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"pntd.0008905.ref054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0353-9","article-title":"Innate, adaptive, and cell-autonomous immunity against Toxoplasma gondii infection","volume":"51","author":"M Sasai","year":"2019","journal-title":"Exp Mol Med"},{"key":"pntd.0008905.ref055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"MO Li","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"pntd.0008905.ref056","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1189\/jlb.1102574","article-title":"Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation","volume":"74","author":"JW Streilein","year":"2003","journal-title":"J Leukoc Biol"},{"key":"pntd.0008905.ref057","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1124\/pr.56.2.7","article-title":"The significance of vasoactive intestinal peptide in immunomodulation","volume":"56","author":"M Delgado","year":"2004","journal-title":"Pharmacol Rev"},{"key":"pntd.0008905.ref058","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4161\/cam.1.3.5062","article-title":"TGFbeta and retinoic acid intersect in immune-regulation","volume":"1","author":"D Mucida","year":"2007","journal-title":"Cell Adhes Migr"},{"key":"pntd.0008905.ref059","volume-title":"Ocular Periphery and Disorders","author":"DA Dartt","year":"2011"},{"key":"pntd.0008905.ref060","first-page":"246856","article-title":"The alpha-melanocyte stimulating hormone induces conversion of effector T cells into Treg cells","volume":"2011","author":"AW Taylor","year":"2011","journal-title":"J Transp Secur"},{"key":"pntd.0008905.ref061","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/08830185.2012.740535","article-title":"Mechanisms of immune privilege in the posterior eye","volume":"32","author":"J Stein-Streilein","year":"2013","journal-title":"Int Rev Immunol"},{"key":"pntd.0008905.ref062","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0002-9440(10)64444-6","article-title":"Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis","volume":"161","author":"C Broderick","year":"2002","journal-title":"Am J Pathol"},{"key":"pntd.0008905.ref063","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1167\/iovs.09-3602","article-title":"Role of the immune modulator programmed cell death-1 during development and apoptosis of mouse retinal ganglion cells","volume":"50","author":"L Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"pntd.0008905.ref064","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.exer.2006.08.005","article-title":"Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta","volume":"83","author":"S Sugita","year":"2006","journal-title":"Exp Eye Res"},{"key":"pntd.0008905.ref065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.exer.2007.09.007","article-title":"Functional expression of B7H1 on retinal pigment epithelial cells","volume":"86","author":"Y Usui","year":"2008","journal-title":"Exp Eye Res"},{"key":"pntd.0008905.ref066","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09273940802491884","article-title":"Constitutive neuronal expression of the immune regulator, programmed death 1 (PD-1), identified during experimental autoimmune uveitis","volume":"17","author":"L Chen","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"pntd.0008905.ref067","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jneuroim.2006.06.002","article-title":"Expression analysis of immune response genes of M\u00fcller cells infected with Toxoplasma gondii","volume":"179","author":"BC Knight","year":"2006","journal-title":"J Neuroimmunol"},{"key":"pntd.0008905.ref068","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1128\/IAI.69.4.2589-2595.2001","article-title":"Immunological Studies of Chronic Ocular Toxoplasmosis: Up-Regulation of Major Histocompatibility Complex Class I and Transforming Growth Factor \u03b2 and a Protective Role for Interleukin-6","volume":"69","author":"RE Lyons","year":"2001","journal-title":"Infect Immun"},{"key":"pntd.0008905.ref069","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-3024.2006.00874.x","article-title":"Ocular toxoplasmosis: in the storm of the eye","volume":"28","author":"LA Jones","year":"2006","journal-title":"Parasite Immunol"},{"key":"pntd.0008905.ref070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/expr.1994.1022","article-title":"Toxoplasma gondii: Acquired Ocular Toxoplasmosis in the Murine Model, Protective Role of TNF-\u03b1 and IFN-\u03b3","volume":"78","author":"RT Gazzinelli","year":"1994","journal-title":"Exp Parasitol"},{"key":"pntd.0008905.ref071","first-page":"742","article-title":"Development of murine models of ocular toxoplasmosis and preliminary results of ocular inflammatory transcriptome","volume":"32","author":"A Sauer","year":"2009","journal-title":"J Fr Ophtalmol"},{"key":"pntd.0008905.ref072","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/IAI.02985-14","article-title":"Interleukin-6-driven inflammatory response induces retinal pathology in a model of ocular toxoplasmosis reactivation","volume":"83","author":"\u00c9 Rochet","year":"2015","journal-title":"Infect Immun"},{"key":"pntd.0008905.ref073","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/IAI.00117-10","article-title":"CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1","volume":"78","author":"E Charles","year":"2010","journal-title":"Infect Immun"},{"key":"pntd.0008905.ref074","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/infdis\/jis486","article-title":"Interleukin 17A as an effective target for anti-inflammatory and antiparasitic treatment of toxoplasmic uveitis","volume":"206","author":"A Sauer","year":"2012","journal-title":"J Infect Dis"},{"key":"pntd.0008905.ref075","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1086\/597478","article-title":"Cytokine profiles in toxoplasmic and viral uveitis","volume":"199","author":"I Lahmar","year":"2009","journal-title":"J Infect Dis"},{"key":"pntd.0008905.ref076","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.coi.2007.07.020","article-title":"Th17: the third member of the effector T cell trilogy","volume":"19","author":"E Bettelli","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"pntd.0008905.ref077","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.coi.2011.07.006","article-title":"Recent advances in the IL-17 cytokine family","volume":"23","author":"SL Gaffen","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"pntd.0008905.ref078","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cyto.2007.09.009","article-title":"Regulation of IL-17 production in human lymphocytes","volume":"41","author":"Z Chen","year":"2008","journal-title":"Cytokine"},{"key":"pntd.0008905.ref079","doi-asserted-by":"crossref","first-page":"9356728","DOI":"10.1155\/2019\/9356728","article-title":"Immune Mediator Profile in Aqueous Humor Differs in Patients with Primary Acquired Ocular Toxoplasmosis and Recurrent Acute Ocular Toxoplasmosis","volume":"2019","author":"C Thieme","year":"2019","journal-title":"Mediat Inflamm"},{"key":"pntd.0008905.ref080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/infdis\/jis640","article-title":"Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis","volume":"207","author":"MS Dutra","year":"2013","journal-title":"J Infect Dis"},{"key":"pntd.0008905.ref081","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bjophthalmol-2012-301490","article-title":"Kinetic analysis of cytokines, chemokines, chemokine receptors and adhesion molecules in murine ocular toxoplasmosis","volume":"96","author":"A Kikumura","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"pntd.0008905.ref082","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ijpara.2013.04.004","article-title":"The local immune response to intraocular Toxoplasma re-challenge: Less pathology and better parasite control through Treg\/Th1\/Th2 induction","volume":"43","author":"A Sauer","year":"2013","journal-title":"Int J Parasitol"},{"key":"pntd.0008905.ref083","doi-asserted-by":"crossref","first-page":"e18139","DOI":"10.1371\/journal.pone.0018139","article-title":"The Effects of Th17 Cytokines on the Inflammatory Mediator Production and Barrier Function of ARPE-19 Cells","volume":"6","author":"Y Chen","year":"2011","journal-title":"PLoS ONE"},{"key":"pntd.0008905.ref084","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"P Ye","year":"2001","journal-title":"J Exp Med"},{"key":"pntd.0008905.ref085","first-page":"6052","article-title":"Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection","volume":"171","author":"S Bennouna","year":"2003","journal-title":"J Immunol Baltim Md 1950"},{"key":"pntd.0008905.ref086","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/IAI.73.1.617-621.2005","article-title":"Interleukin-17\/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection","volume":"73","author":"MN Kelly","year":"2005","journal-title":"Infect Immun"},{"key":"pntd.0008905.ref087","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"B Afzali","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"pntd.0008905.ref088","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"DJ Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"pntd.0008905.ref089","first-page":"1090","article-title":"Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis","volume":"23","author":"A de-la-Torre","year":"2009","journal-title":"Eye Lond Engl"},{"key":"pntd.0008905.ref090","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3201\/eid1204.051081","article-title":"Recently acquired Toxoplasma gondii infection","volume":"12","author":"JL Jones","year":"2006","journal-title":"Brazil Emerg Infect Dis"},{"key":"pntd.0008905.ref091","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/IIO.0b013e3181d26bf4","article-title":"Ocular toxoplasmosis in the developing world","volume":"50","author":"JF Arevalo","year":"2010","journal-title":"Int Ophthalmol Clin"},{"key":"pntd.0008905.ref092","doi-asserted-by":"crossref","first-page":"e2541","DOI":"10.1371\/journal.pntd.0002541","article-title":"Severe South American ocular toxoplasmosis is associated with decreased Ifn-\u03b3\/Il-17a and increased Il-6\/Il-13 intraocular levels","volume":"7","author":"A de-la-Torre","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008905.ref093","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0950268899002800","article-title":"Incidence of symptomatic Toxoplasma eye disease: aetiology and public health implications","volume":"123","author":"RE Gilbert","year":"1999","journal-title":"Epidemiol Infect"},{"key":"pntd.0008905.ref094","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s004360050311","article-title":"Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain","volume":"83","author":"HG Fischer","year":"1997","journal-title":"Parasitol Res"},{"key":"pntd.0008905.ref095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2004.10.023","article-title":"The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells","volume":"160","author":"BC Knight","year":"2005","journal-title":"J Neuroimmunol"},{"key":"pntd.0008905.ref096","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3201\/eid1202.041115","article-title":"Waterborne toxoplasmosis, Brazil, from field to gene","volume":"12","author":"L de Moura","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"pntd.0008905.ref097","doi-asserted-by":"crossref","first-page":"e0214310","DOI":"10.1371\/journal.pone.0214310","article-title":"Type I ROP16 regulates retinal inflammatory responses during ocular toxoplasmosis","volume":"14","author":"E Rochet","year":"2019","journal-title":"PLoS ONE"},{"key":"pntd.0008905.ref098","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpara.2018.08.007","article-title":"Clonal and atypical Toxoplasma strain differences in virulence vary with mouse sub-species","volume":"49","author":"MA Hassan","year":"2019","journal-title":"Int J Parasitol"},{"issue":"4","key":"pntd.0008905.ref099","first-page":"e00597","article-title":"Genetic Polymorphisms in Cytokine Genes in Colombian Patients with Ocular Toxoplasmosis","volume":"86","author":"CA Naranjo-Galvis","year":"2018","journal-title":"Infect Immun"},{"key":"pntd.0008905.ref100","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1128\/IAI.59.9.3287-3290.1991","article-title":"Role of beta interferon in resistance to Toxoplasma gondii infection","volume":"59","author":"MA Orellana","year":"1991","journal-title":"Infect Immun"},{"key":"pntd.0008905.ref101","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/IAI.64.10.4188-4196.1996","article-title":"Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells","volume":"64","author":"CN Nagineni","year":"1996","journal-title":"Infect Immun"},{"key":"pntd.0008905.ref102","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/cmi.12423","article-title":"Mechanisms of interferon-beta-induced inhibition of Toxoplasma gondii growth in murine macrophages and embryonic fibroblasts: role of immunity-related GTPase M1","volume":"17","author":"ME Mahmoud","year":"2015","journal-title":"Cell Microbiol"},{"key":"pntd.0008905.ref103","doi-asserted-by":"crossref","first-page":"e1003779","DOI":"10.1371\/journal.ppat.1003779","article-title":"Transcriptional analysis of murine macrophages infected with different Toxoplasma strains identifies novel regulation of host signaling pathways","volume":"9","author":"MB Melo","year":"2013","journal-title":"PLoS Pathog"},{"key":"pntd.0008905.ref104","doi-asserted-by":"crossref","first-page":"17480","DOI":"10.1073\/pnas.1904637116","article-title":"Toxoplasma gondii effector TgIST blocks type I interferon signaling to promote infection","volume":"116","author":"SK Matta","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pntd.0008905.ref105","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.it.2018.08.008","article-title":"Type III Interferons in Antiviral Defenses at Barrier Surfaces","volume":"39","author":"AI Wells","year":"2018","journal-title":"Trends Immunol"},{"key":"pntd.0008905.ref106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2019.02.007","article-title":"Interferon-\u03bb3 Promotes Epithelial Defense and Barrier Function Against Cryptosporidium parvum Infection","volume":"8","author":"SH Ferguson","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"pntd.0008905.ref107","doi-asserted-by":"crossref","first-page":"284ra59","DOI":"10.1126\/scitranslmed.aaa4304","article-title":"Interferon-\u03bb restricts West Nile virus neuroinvasion by tightening the blood-brain barrier","volume":"7","author":"HM Lazear","year":"2015","journal-title":"Sci Transl Med"},{"key":"pntd.0008905.ref108","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1017\/S0031182015001973","article-title":"Effect of Toxoplasma gondii infection on the junctional complex of retinal pigment epithelial cells","volume":"143","author":"AR Nogueira","year":"2016","journal-title":"Parasitology"},{"key":"pntd.0008905.ref109","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","article-title":"Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1","volume":"76","author":"PJ Mease","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"pntd.0008905.ref110","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa1503824","article-title":"Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis","volume":"373","author":"M Lebwohl","year":"2015","journal-title":"N Engl J Med"},{"key":"pntd.0008905.ref111","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis","volume":"373","author":"D Baeten","year":"2015","journal-title":"N Engl J Med"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T13:34:00Z","timestamp":1609421640000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008905"}},"subtitle":[],"editor":[{"given":"Aysegul","family":"Taylan Ozkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":111,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008905","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,31]]}}}